مواقع التدريسيينجامعة الكوفة
Suhaer Zeki Saeed Al-Fadhel
Assistant Professor

Suhaer Zeki Saeed Al-Fadhel

0Publications
0Interests

About

Bachlore`s from science faculity
master in biochemistry from faculity of medicine
and PhD from science faculity

Research Interests

2

Publications

6
2022

Serum adiponectin and ghrelin in polycystic ovarian syndrome and its correlation with insulin resistance

AuthorsDunia M. Mohammed Ali, Suhaer Zeki Al-Fadhel , Nibras H. Abdulsada Al-Ghuraibawi ,
JournalInternational journal of health science
Abstract

Background: Polycystic ovarian syndrome (PCOS) considered one of the main complex and heterogeneous endocrine syndromes of females in the pregnancy age , it is commonly accompanied by insulin resistance (IR). Current study aimed to compare adiponectin and ghrelin levels between females with PCOS and healthy females, also inspect the association between ghrelin and adiponectin levels in addition to predict their use as diagnostic factors for the disease, finally to study the connection between adiponectin and ghrelin with lipid profiles and IR in PCOS females . Subjects and Methods: The present case-control study involved 120 females; 60 with PCOS and 60 age-matched healthy controls. Fasting serum levels of glucose, lipid profiles, insulin, adiponectin, ghrelin, follicle stimulating hormone (FSH), luteinizing hormone (LH), testosterone and sex hormone-binding globulin (SHBG), were assessed. Insulin resistance was assessed by homeostasis model assessment (HOMA-IR) and body mass index (BMI) also estimated. The statistical analysis of the data were done by using SPSS 22 . Results: The findings revealed that serum adiponectin level elevated significantly in females with PCOS as compared with control, while ghrelin level decreased significantly in females with PCOS in compared to control. Furthermore, results showed that adiponectin levels were positively correlated with BMI, fasting glucose (FG), low density lipoproteincholesterol (LDL-C), triglycerides (TG), total cholesterol (TC), insulin

2022

Differences in Clinical Outcomes between Smokers and NonSmokers infected with COVID-19

AuthorsN H Abdulsada Al-Ghuraibawi , , S Zeki Al-Fadhel, D M Mohammed Ali , H Kadhem Al-Hakeim
JournalArchives of Razi Institute
Abstract

Cigarette smoking is a risk factor associated with different diseases, claiming millions of lives annually. Smoking status has been studied for a long time and proved to be a major cause of smokers' decreased immunity. In the present pandemic COVID-19 disease, there was an unclear belief about the effect of smoking on patients with COVID-19. Therefore, the current cross-sectional study aimed to evaluate the effect of cigarette smoking on the sequelae of COVID-19. This cross-sectional study involved 200 COVID-19 patients (114 males and 86 females) aged 13-77 years. A number of 87 patients were smokers, and the rest of them were nonsmokers. All patients underwent a comprehensive laboratory assessment and diagnosis by full medical history by the physicians. The results indicated a significant difference (P<0.001) between smokers and non-smokers in terms of hypertension, anticoagulant, steroid therapy, pulmonary lesion, oxygen saturation, and duration of disease. As an overall conclusion, it can be stated that COVID-19 is less severe in smokers and they require less intensive treatment.

2020

Serum chemerin and visfatin levels and their ratio as possible diagnostic parameters of rheumatoid arthritis

AuthorsDunia M. Mohammed Ali, Suhaer Zeki Al-Fadhel, Nibras H. Abdulsada Al-Ghuraibawi3, Hussein Kadhem Al-Hakeim
JournalReumatologia
Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory disease affecting the synovium and articular cartilage that initiates joint damage. Rheumatoid arthritis is associated with a change in many inflammatory biomarkers. The present study aims to examine the diagnostic ability of inflammatory adipocytokines (chemerin and visfatin) and their ratio for RA disease.

2020

Serum cytokine dependent hematopoietic cell linker (CLNK) as a predictor for the duration of illness in type 2 diabetes mellitus

AuthorsSuhaer Zeki Al-Fadhel, , Nibras H. Abdulsada Al-Ghuraibawi, Dunia M. Mohammed Ali & Hussein Kadhem Al-Hakeim
JournalJournal of Diabetes & Metabolic Disorders
Abstract

Type 2 diabetes mellitus (T2DM) is an endocrine illness associated with various changes in the immune system and adaptor protein levels. Cytokine dependent hematopoietic cell linker (CLNK) is an adapter protein that regulates immune receptor signaling and acts as a regulator of the receptor signaling of T-cells and natural killer cells. The role of CLNK in T2DM is not studied previously. In the present study, serum CLNK level was measured and correlated with some sociodemographic and insulin resistance (IR) parameters. To achieve these goals, we measured CLNK level and insulin parameters (glucose, insulin, HbA1c, in addition to the calculation of the functions of IR (HOMA2IR), insulin sensitivity (HOMA%S), and beta-cell function (HOMA%B)) in 60 T2DM patients and 30 controls. The results indicated a significant increase (p < 0.05) in serum CLNK in patients group in comparison with the controls. Multivariate generalized linear model (GLM) analysis revealed no significant effect of age, BMI, and sex on the CLNK level. The results of tests for between-subjects showed that the CLNK affects diagnosis significantly (F = 7.445, p = 0.008, partial η2 = 0.081) and its effect is approximately the same as the effect of insulin (F = 8.107, p = 0.006, partial η2 = 0.087). The correlation study showed a highly significant positive correlation between CLNK and the duration of disease (rho = 0.420, p < 0.001). It can be concluded that the increase CLNK in T2DM revealing the role of the adaptor proteins level in the progression of the disease and may act as a predictor for diabetes complications, which deserves more investigations

2019

Correlation of Serum Dynorphin /KOR System with Serum IL-6 and IL-10 in Major Depressive Disorder

AuthorsSuhaer Zeki Al-Fadhel
JournalJournal of Global Pharma Technology
Abstract

A case-control study was applied to improve if there is a relation between endogenous opioid dynorhpin (Dyn) and its receptor KOR with serum interleukin-6 (IL-6) and interleukin-10 (IL-10) among MDD patients versus a group of apparently healthy subjects. The study included 60 depressed pretreatment male patients and 30 (age and gender matched) controls. The serum Dyn, KOR, IL-6 and IL-10 levels were measured and the relation between these factors was obtained in addition to comparison of these factors between MDD patients and control group. Each parameter was determined by using ELISA technique. The comparison between both groups indicated a significance increase (p<0.05) in Dyn, IL-6 and IL-10 in MDD group comparing with controls. Whereas KOR didn’t show any significant difference. The correlation results indicated that there was no correlation between the two systems (endogenous opioid and immune systems). The conclusion of the study is that there was no relation between Dyn/KOR with inflammatory marker IL-6 and IL-10. This finding indicates that there is no effect of endogenous dyn on the immune function.

2019

Development of a Novel Neuro-immune and Opioid-Associated Fingerprint with a Cross-Validated Ability to Identify and Authenticate Unknown Patients with Major Depression: Far Beyond Differentiation, Discrimination, and Classification

AuthorsHussein Kadhem Al-Hakeim1 , & Suhaer Zeki Al-Fadhel2 & Arafat Hussein Al-Dujaili3 & Andre Carvalho4,5 & Sira Sriswasdi6 & Michael Maes
JournalMolecular Neurobiology
Abstract

Major depressive disorder (MDD) is characterized by signaling aberrations in interleukin (IL)-6, IL-10, beta-endorphins as well as μ (MOR) and κ (KOR) opioid receptors. Here we examined whether these biomarkers may aid in the classification of unknown subjects into the target class MDD. The aforementioned biomarkers were assayed in 60 first-episode, drug-naïve depressed patients and 30 controls. We used joint principal component analysis (PCA) performed on all subjects to check whether subjects cluster by classes; support vector machine (SVM) with 10-fold validation; and linear discriminant analysis (LDA) and SIMCA performed on calibration and validation sets and we computed the figures of merit and learnt from the data. PCA shows that both groups were well separated using the first three PCs, while correlation loadings show that all five biomarkers have discriminatory value. SVM and LDA yielded an accuracy of 100% in validation samples.

View details